Douglas Scheesley

Director, Research Productivity Analytics

GSK

Douglas Scheesley is the business owner for a drug development-wide ELN and influencer in the overall data strategy at GlaxoSmithKline. Starting as an analytical chemist, he has been involved in numerous tech and scientific projects across small and large-molecule. Combining his experience in science, coding, multivariate analysis, automation, and project management, Doug is passionate about improving the process of generating scientific knowledge to help the patient do more, feel better, and live longer.